Avaliação da qualidade de vida em pacientes submetidos ao tratamento com antineoplásicos: aplicabilidade do instrumento EORTC QLQ - C30
Carregando...
Data
Autores
Título da Revista
ISSN da Revista
Título de Volume
Editor
Universidade Estadual de Ponta Grossa
Resumo
INTRODUÇÃO: A incidência do câncer tem crescido, aumentando o número de diagnósticos e tratamentos, dentre os tratamentos terapêuticos podemos destacar a quimioterapia com antineoplásicos endovenosos e orais, objetivando a cura ou alívio dos sintomas agravantes do câncer. Entretanto, o uso da substância terapêutica traz consigo uma série de efeitos colaterais. OBJETIVO: Avaliar a qualidade de vida de pacientes oncológicos que realizam tratamentos com antineoplásicos. METODOLOGIA: estudo descritivo dividido em duas etapas, no qual a primeira caracterizou-se como realização de uma revisão de escopo objetivando mapear instrumentos para Avaliação da Qualidade de Vida de Pacientes que Realizam Tratamentos com Antineoplásicos, a segunda etapa foi constituída por estudo exploratório, de abordagem quantitativa fundamentado no instrumento da European Organizacion for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). RESULTADOS: o estudo analisou a prevalência de pacientes submetidos ao tratamento com antineoplásicos em unidades quimioterápicas de duas instituições referências na cidade de Ponta Grossa (PR). Em sua maioria, do sexo feminino, de pele branca, casado, com ensino médio e com idade entre 50 e 60 anos. Foram observados ainda, maior prevalência entre indivíduos com câncer de mama, seguido por câncer do intestino, em tratamento quimioterápico e sem metástase. No que se refere a qualidade de vida, observou-se dificuldades em realizar atividades com caminhadas longas e realização de grandes esforços. Sobre a percepção em relação a sua saúde, os participantes relataram como boa. CONCLUSÃO: instrumentos para avaliar a qualidade de vida de pacientes que realizam tratamentos com antineoplásicos colaboram para o conhecimento das principais dificuldades e efeitos colaterais enfrentados por esses pacientes, destacando que o conceito de qualidade de vida pode variar de pessoa para pessoa, levando em consideração um amplo ambiente e contextos inseridos, assim como tipos de neoplasias enfrentadas.
INTRODUCTION: The incidence of cancer has been increasing, leading to a higher number of diagnoses and treatments. Among therapeutic treatments, chemotherapy with intravenous and oral antineoplastics stands out, aiming for either a cure or relief from worsening cancer symptoms. However, the use of these therapeutic substances comes with a range of side effects. OBJECTIVE: To evaluate the quality of life of cancer patients undergoing treatment with antineoplastics. OBJECTIVE: To assess the quality of life of cancer patients undergoing antineoplastic treatments. METHODOLOGY: descriptive study divided into two stages, in which the first involved conducting a scoping review aimed at mapping instruments for Assessing the Quality of Life of Patients Undergoing Antineoplastic Treatments. The second stage consisted of an exploratory study, with a quantitative approach based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). RESULTS: The study analyzed the prevalence of patients undergoing treatment with antineoplastics in chemotherapy units of two reference institutions in the city of Ponta Grossa (PR). Most of them were women, with white skin, married, with a high school education, and aged between 50 and 60 years. It was also observed a higher prevalence among individuals with breast cancer, followed by intestinal cancer, who were undergoing chemotherapy treatment and had no metastasis. Regarding quality of life, difficulties were noted in performing activities that involved long walks and heavy effort. Regarding their perception of their health, the participants reported it as good. CONCLUSION: instruments to assess the quality of life of patients undergoing treatments with antineoplastic drugs help to understand the main difficulties and side effects faced by these patients, highlighting that the concept of quality of life can vary from person to person, taking into account a wide environment and different contexts, as well as the types of cancers being dealt with.
INTRODUCTION: The incidence of cancer has been increasing, leading to a higher number of diagnoses and treatments. Among therapeutic treatments, chemotherapy with intravenous and oral antineoplastics stands out, aiming for either a cure or relief from worsening cancer symptoms. However, the use of these therapeutic substances comes with a range of side effects. OBJECTIVE: To evaluate the quality of life of cancer patients undergoing treatment with antineoplastics. OBJECTIVE: To assess the quality of life of cancer patients undergoing antineoplastic treatments. METHODOLOGY: descriptive study divided into two stages, in which the first involved conducting a scoping review aimed at mapping instruments for Assessing the Quality of Life of Patients Undergoing Antineoplastic Treatments. The second stage consisted of an exploratory study, with a quantitative approach based on the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire Core 30 (EORTC QLQ-C30). RESULTS: The study analyzed the prevalence of patients undergoing treatment with antineoplastics in chemotherapy units of two reference institutions in the city of Ponta Grossa (PR). Most of them were women, with white skin, married, with a high school education, and aged between 50 and 60 years. It was also observed a higher prevalence among individuals with breast cancer, followed by intestinal cancer, who were undergoing chemotherapy treatment and had no metastasis. Regarding quality of life, difficulties were noted in performing activities that involved long walks and heavy effort. Regarding their perception of their health, the participants reported it as good. CONCLUSION: instruments to assess the quality of life of patients undergoing treatments with antineoplastic drugs help to understand the main difficulties and side effects faced by these patients, highlighting that the concept of quality of life can vary from person to person, taking into account a wide environment and different contexts, as well as the types of cancers being dealt with.
Descrição
Citação
FEITOSA, Georgiana do Nascimento. Avaliação da qualidade de vida em pacientes submetidos ao tratamento com antineoplásicos: aplicabilidade do instrumento EORTC QLQ - C30. 2026. Dissertação (Mestrado em Ciências da Saúde) – Universidade Estadual de Ponta Grossa, Ponta Grossa, 2026.
Avaliação
Revisão
Suplementado Por
Referenciado Por
Licença Creative Commons
Exceto quando indicado de outra forma, a licença deste item é descrita como http://purl.org/coar/access_right/c_abf2
